Alexander Fefer was affiliated with the University of Washington in the United States. Their research primarily focused on the intersection of mathematics and decision sciences, with significant contributions in statistics and probability, management science and operations research, computational theory and mathematics, as well as economics and econometrics.
Their scholarly output included extensive work on statistical methods, particularly in clinical trials and optimal experimental design. Key research topics covered by Fefer included:
Fefer's publication record featured collaborations with various frequent coauthors such as Sergey Tarima, James L. Rosenberger, Kelly Van Lancker, Madeline Bauer, and Jonathan W. Bartlett. Their work was often published in venues including:
Notable recent papers by Fefer included:
Throughout their career, Fefer's research emphasized methods that address challenges in clinical trial design and analysis, including trials affected by external disruptions such as the COVID-19 pandemic. Their interdisciplinary approach integrated advanced statistical inference techniques with practical decision sciences applications, delivering insights relevant to health systems and bioanalytics.
Glucksberg H;Storb R;Fefer A;Buckner Cd
E Thomas;R Storb;R A Clift;A Fefer
Thomas Ed;Storb R;Clift Ra;Fefer A
ED Thomas;CD Buckner;M Banaji;RA Clift
K M Sullivan;P L Weiden;R Storb;R P Witherspoon
PJ Martin;JA Hansen;CD Buckner;JE Sanders
KM Sullivan;PL Weiden;R Storb;RP Witherspoon
E D Thomas;R A Clift;A Fefer;F R Appelbaum
Oliver W. Press;Paul G. Ramsey;Eric B. Larson;Alexander Fefer
P D Greenberg;M A Cheever;A Fefer
K M Sullivan;R Storb;C D Buckner;A Fefer
R. Storb;E. D. Thomas;C. D. Buckner;R. A. Clift
E.D. Thomas;R.A. Clift;J. Hersman;J.E. Sanders
M A Cheever;P D Greenberg;A Fefer;S Gillis
E Donnall Thomas;Rainer Storb;Alexander Fefer;SherillJ Slichter
F R Appelbaum;K M Sullivan;C D Buckner;R A Clift
R. Storb;E. D. Thomas;P. L. Weiden;C. D. Buckner;C. D. Buckner;C. D. Buckner
C. D. Buckner;R. H. Rudolph;A. Fefer;R. A. Clift
H. J. Deeg;H. M. Shulman;J. E. Anderson;E. M. Bryant
Appelbaum Fr;Dahlberg S;Thomas Ed;Buckner Cd
John A. Thompson;Douglas J. Lee;Pamela Kidd;Ellen Rubin
R Storb;E Gluckman;E D Thomas;C D Buckner
HG Klingemann;R Storb;A Fefer;HJ Deeg
K Atkinson;V Farewell;R Storb;Tsoi
If you think any of the details on this page are incorrect, let us know.
For those interested in Immunology, exploring related healthcare degrees can broaden career opportunities. Transitioning within nursing specialties is a common pathway. For example, a fnp to acute care np bridge program helps Family Nurse Practitioners move into acute care settings, allowing for specialized patient care that often intersects with immunological disorders.
Accelerated nursing programs are crucial for students aiming to fast-track their careers. Many students benefit from accelerated np programs online, which offer flexible learning models without compromising quality. These programs can support one’s growth in understanding immune system-related health issues at a practitioner level.
For those without a nursing background, starting an accelerated nursing education is achievable. Both online absn programs for non nurses and accelerated bsn programs for non nurses provide practical and accessible entry points. These paths are designed to quickly prepare students for nursing roles, ultimately supporting diverse career options within immunology and related fields.
